45 research outputs found
On the Analysis of Non-stationary Impedance Spectra
In this work we study the possibility to analyze the non-stationary impedance spectra by employing standard equivalent circuits. For this purpose, the dynamic multi-frequency analysis (DMFA) is introduced and compared with a set of consecutive stationary impedance spectra. In order to prove the hypothesis, the data are obtained by the simulation in the time domain of the electron transfer process between an electrode and a free-diffusing redox couple in solution. During the simulation, the system is perturbed with a cyclic voltammetry super-imposed to a small multisine perturbation (DMFA) or with a series of stationary impedance spectroscopies. Also, a new fitting algorithm, which takes into account the correlation between consecutive spectra, is proposed and tested. Although the Randles circuit can be used to fit both dynamic and stationary impedance spectra, the values of the fitting parameters are different and depend on the direction of the scan and on the rate. This is related to the influence of the diffusion profile on the fitting parameters
Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes
AIM: To report real-life data on the use of an intravitreal fluocinolone acetonide implant in the treatment of refractory diabetic macular edema (DME) in pars plana vitrectomized (PPV) and non-PPV eyes.
METHODS: This was a comparative retrospective observational study of 23 eyes with chronic DME. Best-corrected visual acuity (BCVA) and central macular thickness (CMT) were recorded at baseline, 1, 4 and 12mo. Descriptive statistics and non-parametric tests were performed to analyze and compare PPV and non-PPV eyes.
RESULTS: Seven PPV and 16 non-PPV eyes were included in the study. Median BCVA in the non-PPV group varied from 0.65 logMAR [Interquartile range (IQR): 0.40] at baseline to 0.42 logMAR (IQR: 0.40) at 12mo. Median CMT varied from 430 ”m (IQR: 131.3) at baseline to 317 ”m (IQR: 107.5) at 12mo. Median BCVA in the PPV group varied from 0.60 logMAR (IQR: 0.62) at baseline to 0.74 logMAR (IQR: 0.34) at 12mo. Median CMT varied from 483 ”m (IQR: 146) at baseline to 397 ”m (IQR: 132) at 12mo. Of 0/7 eyes and 1/16 eyes in the PPV and non-PPV eyes respectively had a baseline visual acuity of 6/12 or better (0.3 logMAR). At last follow up, 1/7 and 5/16 eyes in the PPV and non-PPV group respectively achieved a visual acuity of 6/12 or better.
CONCLUSION: Visual outcomes are modest following the use of the fluocinolone acetonide implant for chronic DME. The steroid implant is a useful treatment option in the management of refractory DME in vitrectomized and non-vitrectmized eyes
Isolation and characterization of mammary epithelial cells derived from GoÌttingen Minipigs: A comparative study versus hybrid pig cells from the IMI-ConcePTION Project
: The value of pig as "large animal model" is a well-known tool for translational medicine, but it can also be beneficial in studying animal health in a one-health vision. The ConcePTION Project aims to provide new information about the risks associated with medication use during breastfeeding, as this information is not available for most commonly used drugs. In the IMI-Conception context, GoÌttingen Minipigs have been preferred to hybrid pigs for their genetic stability and microbiological control. For the first time, in the present research, three primary cell cultures of mammary epithelial cells were isolated and characterized from GoÌttingen Minipigs (mpMECs), including their ability to create the epithelial barrier. In addition, a comparative analysis between GoÌttingen Minipigs and commercial hybrid pig mammary epithelial cells (pMECs) was conducted. Epithelial markers: CKs, CK18, E-CAD, ZO-1 and OCL, were expressed in both mpMECs and pMECs. RT2 Profiler PCR Array Pig Drug Transporters showed a similar profile in mRNA drug transporters. No difference in energy production under basal metabolic condition was evidenced, while under stressed state, a different metabolic behaviour was shown between mpMECs vs pMECs. TEER measurement and sodium fluorescein transport, indicated that mpMECs were able to create an epithelial barrier, although, this turned out to be less compact than pMECs. By comparing mpMECs with mammary epithelial cells isolated from Hybrid pigs (pMECs), although both cell lines have morphological and phenotypic characteristics that make them both useful in barrier studies, some specific differences exist and must be considered in a translational perspective
Electrochemical impedance spectroscopy beyond linearity and stationarity - a critical review
Electrochemical impedance spectroscopy (EIS) is a widely used experimental
technique for characterising materials and electrode reactions by observing
their frequency-dependent impedance. Classical EIS measurements require the
electrochemical process to behave as a linear time-invariant system. However,
electrochemical processes do not naturally satisfy this assumption: the
relation between voltage and current is inherently nonlinear and evolves over
time. Examples include the corrosion of metal substrates and the cycling of
Li-ion batteries. As such, classical EIS only offers models linearised at
specific operating points. During the last decade, solutions were developed for
estimating nonlinear and time-varying impedances, contributing to more general
models. In this paper, we review the concept of impedance beyond linearity and
stationarity, and detail different methods to estimate this from measured
current and voltage data, with emphasis on frequency domain approaches using
multisine excitation. In addition to a mathematical discussion, we measure and
provide examples demonstrating impedance estimation for a Li-ion battery,
beyond linearity and stationarity, both while resting and while charging
Sense of smell in chronic rhinosinusitis: A multicentric study on 811 patients
Introduction: The impairment of the sense of smell is often related to chronic rhinosinusitis (CRS) with or without nasal polyps (CRSwNP, CRSsNP). CRSwNP is a frequent condition that drastically worsens the quality of life of those affected; it has a higher prevalence than CRSsNP. CRSwNP patients experience severe loss of smell with earlier presentation and are more likely to experience recurrence of their symptoms, often requiring revision surgery. Methods: The present study performed a multicentric data collection, enrolling 811 patients with CRS divided according to the inflammatory endotype (Type 2 and non-Type 2). All patients were referred for nasal endoscopy for the assessment of nasal polyposis using nasal polyp score (NPS); Sniffin' Sticks olfactory test were performed to measure olfactory function, and SNOT-22 (22-item sinonasal outcome test) questionnaire was used to assess patients' quality of life; allergic status was evaluated with skin prick test and nasal cytology completed the evaluation when available. Results: Data showed that Type 2 inflammation is more common than non-type 2 (656 patients versus 155) and patients suffer from worse quality of life and nasal polyp score. Moreover, 86.1% of patients with Type 2 CRSwNP were affected by a dysfunction of the sense of smell while it involved a lesser percentage of non-Type 2 patients. Indeed, these data give us new information about type-2 inflammation patients' characteristics. Discussion: The present study confirms that olfactory function weights on patients' QoL and it represents an important therapeutic goal that can also improve patients' compliance when achieved. In a future - and present - perspective of rhinological precision medicine, an impairment of the sense of smell could help the clinician to characterize patients better and to choose the best treatment available
Diagnostic therapeutic assistance pathway (PDTA) of type 2 chronic rhinosinusitis
Chronic rhinosinusitis (CRS) is a complex and heterogeneous disorder whose etiopathogenetic picture is not yet completely known and is classically divided into CRS with (CRSwNP) and without nasal polyps (CRSsNP). But today the distinction is made with type 2 and nontype 2 variants. A rational and defined pathway for the diagnosis of chronic rhinosinusitis is an indispensable means to be able to arrive at a correct identification of the patient. This typing is essential to be able to arrive at the correct course of treatment, which turns out to be different for different types of patients. For this reason, the realization of a diagnostic therapeutic pathway represents a fundamental way for the otolaryngologist specialist but not only, since today diagnostics has a multidisciplinary framework. In the present work, precise indications have been developed to arrive at a correct diagnosis. The various diagnostic pathways and processes to arrive at a correct therapeutic framing have been highlighted. Therapy ranging from medical therapy to surgical therapy without neglecting the new biological therapies. It does not represent a guideline but a diagnostic method that can be adapted to all the various territorial realities
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL)
Background
Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and reduced health-related quality of life. Findings from clinical trials have demonstrated the effectiveness of dupilumab in CRSwNP, although real-world evidence is still limited.
Methods
This Phase IV real-life, observational, multicenter study assessed the effectiveness and safety of dupilumab in patients with severe uncontrolled CRSwNP (nâ=â648) over the first year of treatment. We collected data at baseline and after 1, 3, 6, 9, and 12âmonths of follow-up. We focused on nasal polyps score (NPS), symptoms, and olfactory function. We stratified outcomes by comorbidities, previous surgery, and adherence to intranasal corticosteroids, and examined the success rates based on current guidelines, as well as potential predictors of response at each timepoint.
Results
We observed a significant decrease in NPS from a median value of 6 (IQR 5â6) at baseline to 1.0 (IQR 0.0â2.0) at 12âmonths (pâ<â.001), and a significant decrease in Sino-Nasal Outcomes Test-22 (SNOT-22) from a median score of 58 (IQR 49â70) at baseline to 11 (IQR 6â21; pâ<â.001) at 12âmonths. Sniffin' Sticks scores showed a significant increase over 12âmonths (pâ<â.001) compared to baseline. The results were unaffected by concomitant diseases, number of previous surgeries, and adherence to topical steroids, except for minor differences in rapidity of action. An excellent-moderate response was observed in 96.9% of patients at 12âmonths based on EPOS 2020 criteria.
Conclusions
Our findings from this large-scale real-life study support the effectiveness of dupilumab as an add-on therapy in patients with severe uncontrolled CRSwNP in reducing polyp size and improving the quality of life, severity of symptoms, nasal congestion, and smell
BroncaltÂź, class ii medical device, in patients with chronic relapsed upper airways disease: A survey in clinical practice
Chronic respiratory otorhinolaryngological (ORL) diseases may exacerbate. BroncaltÂź is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It could exert a safe and effective anti-inflammatory, washing, and antimicrobial activity. The current survey, conducted in clinical practice of 84 Italian ORL centers, evaluated its safety and efficacy in the treatment of patients with exacerbated chronic upper airways disease. The 459 (254 males, mean age 44.7 years) patients were evaluated at baseline (T0) and after a 2-week treatment (T1), treated or not-treated with BroncaltÂź. Signs and symptoms severity were measured by visual analogue scale. BroncaltÂź significantly, quickly, and safely diminished the clinical features in all sub-groups (p<0.001 for all). In conclusion, BroncaltÂź is a class II Medical Device able to exert a safe, quick, and effective activity in patients with relapsed chronic ORL disorders. (www.actabiomedica.it)
IN "POLPO ... SITION" E ALTRI BREVI RACCONTI
Assalito dalla felicitĂ corsi al mare, guardai lâacqua e fui preso da una forza, non mia, non umana che mi trascinĂČ in acqua.
LĂŹ venni rapito da fantastiche sensazioni, lâadrenalina salĂŹ a mille, vidi un enorme creatura che suscitĂČ in me delle emozioni mai provate prima, si era avvicinata talmente tanto che stava per toccarmi e, appena lo fece, il mio corpo si illuminĂČ magicamente, le mie mani iniziarono pian piano ad assottigliarsi, il mio petto diventava sempre piĂč piccolo e tondo e da lĂŹ a poco, ero
diventato un polpo